-
Top Stocks: CollabRx (NASDAQ:CLRX), General Electric Company (NYSE:GE), Shake Shack Inc. (NYSE:SHAK), Toyota Motor Corporation (NYSE:TM), Actinium Pharmaceuticals (NYSEMKT:ATNM)
On March 3, CollabRx, Inc. (NASDAQ:CLRX) announced the closing of its previously announced underwritten public offering of 2,362,205 shares of its common stock at an offering price of $1.27 per common share. In addition, the underwriter exercised the over-allotment option to purchase an additional 354,330 shares. Gross proceeds to CollabRx from this offering are approximately…
-
Why Investors Are Watching: Actinium Pharmaceuticals (NYSEMKT:ATNM), Whiting Petroleum Corp. (NYSE:WLL), Spectra Energy Partners (NYSE:SEP), Ryder System (NYSE:R), NXP Semiconductors (NASDAQ:NXPI)
Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) announced that the Company presented at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum on Monday, February 23rd. On Friday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $3.12. On 25 February, Whiting Petroleum Corp. (NYSE:WLL) reported a loss of $353.7 million in its fourth quarter. On…
-
Traders Alert: Corning Inc. (NYSE:GLW), SandRidge Energy (NYSE:SD), GATX Corp. (NYSE:GMT), Actinium Pharmaceuticals (NYSEMKT:ATNM), Ball Corporation (NYSE:BLL)
Zacks upgraded shares of Corning (NYSE:GLW) from a neutral rating to an outperform rating in a research note released on Wednesday morning. They currently have $30.00 target price on the stock.On Friday shares of Corning Inc. (NYSE:GLW) closed at $24.96. Company’s sales growth for last 5 years was 12.50% and EPS growth for next 5…
-
Biotech Top Gainers: Alcobra (NASDAQ:ADHD), Pfenex Inc. (NYSEMKT:PFNX), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Can-Fite BioPharma (NYSEMKT:CANF), Actinium Pharmaceuticals (NYSEMKT:ATNM)
Alcobra Ltd. (NASDAQ:ADHD) announced Total operating expenses in the fourth quarter and fiscal year 2014 were $6.8 million and $33.1 million, respectively, compared with $5.6 million and $10.3 million in the fourth quarter and fiscal year 2013. Net operating expenses, excluding non-cash stock based compensation, in the fourth quarter and fiscal year 2014 were $6.0…
-
Biotech Top Losers: Acorda Therapeutics (NASDAQ:ACOR), Actinium Pharmaceuticals (NYSEMKT:ATNM), Onconova Therapeutics (NASDAQ:ONTX), Marinus Pharmaceuticals (NASDAQ:MRNS), Bio Blast Pharma (NASDAQ:ORPN)
Acorda Therapeutics Inc. (NASDAQ:ACOR) announced that it will host a conference call and live webcast to report its fourth quarter and year end 2014 financial results on Thursday February 12 at 8:30 a.m. ET. On Tuesday shares of Acorda Therapeutics, Inc. (NASDAQ:ACOR) closed at $36.06. Company’s sales growth for last 5 years was 47.70% and…
-
Stocks Swings: Vale S.A. (NYSE:VALE), Fairpoint Communications (NASDAQ:FRP), Pebblebrook Hotel Trust (NYSE:PEB), China Green Agriculture (NYSE:CGA), Actinium Pharmaceuticals (NYSEMKT:ATNM)
Vale S.A. (NYSE:VALE), said Jan 30, that it plans to slash dividends to the lowest level in eight years in a bid to shore up cash amid spiraling commodities prices. Vale’s management proposed to the board a $2 billion minimum dividend payment for 2015, down from $4.2 billion last year and the lowest outlay since…
-
Keep Eyes on: Walter Investment Management Corp. (NYSE:WAC), Johnson Outdoors Inc. (NASDAQ:JOUT), The Nasdaq OMX Group (NASDAQ:NDAQ), Actinium Pharmaceuticals (NYSEMKT:ATNM), Expedia (NASDAQ:EXPE)
On Feb. 2, Walter Investment Management Corp. (NYSE:WAC) responded to the FHFA’s proposed minimum financial eligibility requirements for Fannie Mae and Freddie Mac Seller/Servicers which were released January 30, 2015. On Friday shares of Walter Investment Management Corp. (NYSE:WAC) closed at $18.30. Company’s sales growth for last 5 years was 55.10% and EPS growth for…
-
Stock in News: Actinium Pharmaceuticals (NYSEMKT:ATNM), Domtar Corporation (NYSE:UFS), Planar Systems Inc. (NASDAQ:PLNR), Grupo Simec S.A.B. (NYSEMKT:SIM), Yum! Brands (NYSE:YUM)
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM), announced the pricing of an underwritten public offering of an aggregate 4,444,444 shares of its common stock and warrants to purchase an aggregate of 3,333,333 shares of the Company’s common stock at a combined price to the public of $4.50. On Friday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at…
-
Stocks on the move: Actinium Pharmaceuticals (NYSEMKT:ATNM), Delta Air Lines (NYSE:DAL), SinoCoking Coal and Coke Chemical Industries (NASDAQ:SCOK), CBOE Holdings (NASDAQ:CBOE), FRGI
Actinium Pharmaceuticals, Inc. (NYSEMKT: ATNM) announced the pricing of an underwritten public offering of an aggregate 4,444,444 shares of its common stock and warrants to purchase an aggregate of 3,333,333 shares of the Company’s common stock at a combined price to the public of $4.50. The shares of common stock and warrants will be issued…